Archives: Publications

Pei Ying Ng # 1, Amy B P Ribet # 1, Qiang Guo # 1 2, Benjamin H Mullin 1 3, Jamie W Y Tan 1, Euphemie Landao-Bassonga 1, Sébastien Stephens 4, Kai Chen 1, Jinbo Yuan 1, Laila Abudulai 1 5 6, Maike Bollen 5 6, Edward T T T Nguyen 1, Jasreen Kular 1, John M Papadimitriou 7, Kent Søe 8 9, Rohan D Teasdale 10, Jiake Xu 1, Robert G...
M. M. Formosa, M. A. Christou & O. Mäkitie Osteoporosis is a metabolic bone disorder which increases fragility fracture risk. Elderly individuals, especially postmenopausal women, are particularly susceptible to osteoporosis. Although rare, osteoporosis...
Qihua Tan, Anaïs Marie Julie Møller, Chuan Qiu, Jonna Skov Madsen, Hui Shen, Troels Bechmann, Jean-Marie Delaisse, Bjarne Winther Kristensen, Hong-Wen Deng, David Karasik & Kent Søe A variability in response of osteoclasts to zoledronic acid is mediated by smoking-associated modification...
Erika Kague1*, Carolina Medina-Gomez2, Simeon A. Boyadjiev3 and Fernando Rivadeneira4 Published Sep 2022 https://doi.org/10.3389/fendo.2022.1020821 Osteoporosis is the most prevalent bone condition in the ageing population. This systemic disease is characterized by microarchitectural deterioration of...
Dylan J.M. Bergen PhD,Antonio Maurizi PhD,Melissa M. Formosa PhD,Georgina L.K. McDonald MSc,Ahmed El-Gazzar PhD,Neelam Hassan MD PhD,Maria-Luisa Brandi MD PhD,José A. Riancho MD PhD,Fernando Rivadeneira MD PhD,Evangelia Ntzani MD PhD,Emma...
Anaïs M J Møller, Jean-Marie Delaisse, Jacob B Olesen, Troels Bechmann, Jonna S Madsen, Kent Søe First published: 15 September 2020DOI: https://doi.org/10.1002/jbm4.10412 Zoledronic acid is a bisphosphonate commonly used to treat...
Chen Shochat, Zhiying Wang, Chenglin Mo, Sarah Nelson, Rajashekar Donaka, Jian Huang, David Karasik, Marco BrottoEndocrinology, Volume 162, Issue 1, January 2021, bqaa189, https://doi.org/10.1210/endocr/bqaa189Published: 17 October 2020 Through a genome-wide analysis of bone mineral density (BMD) and muscle mass,...